The total return over the past 12 months is +59.03% vs. +17.77% for the S&P 500. So far it's up +83.35% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +59.03% | (23.96%) | (31.11%) | N/A | N/A | N/A |
| Total Return CAGR | +59.03% | (23.96%) | (31.11%) | N/A | N/A | N/A |
| Revenue CAGR | (29.12%) | (46.79%) | +19.33% | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | +126.92% | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | +105.23% | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Moderna, Inc. (MRNA)
| Year | Start Value | End Value | MRNA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | 158.55 | 290.70 | +83.35% | +8.94% | +74.41% |
| 2025 | 223.55 | 158.55 | (29.08%) | +17.72% | (46.80%) |
| 2024 | 534.68 | 223.55 | (58.19%) | +24.89% | (83.08%) |
| 2023 | 965.70 | 534.68 | (44.63%) | +26.19% | (70.82%) |
| 2022 | 1365.48 | 965.70 | (29.28%) | (18.17%) | (11.11%) |
| 2021 | 561.67 | 1365.48 | +143.11% | +28.74% | +114.37% |
| 2020 | 105.16 | 561.67 | +434.10% | +18.37% | +415.73% |
| 2019 | 82.10 | 105.16 | +28.09% | +31.22% | (3.13%) |
